Consolidated Balance Sheets - USD ($)	Dec. 31, 2017	Dec. 31, 2016
Current assets
Cash and cash equivalents	$ 6,663,318	$ 1,405,826
Accounts receivable, trade, net of allowance for doubtful accounts of $5,575 and $0 at December 31, 2017 and 2016, respectively	1,021,315	1,193,646
Inventories	1,846,746	1,757,784
Prepaid expenses and other current assets	399,502	270,814
Total current assets	9,930,881	4,628,070
Property and equipment
Leasehold improvements	1,284,491	1,284,491
Furniture and computer equipment	682,466	650,912
Manufacturing and other equipment	1,148,006	922,220
Subtotal	3,114,963	2,857,623
Less: Accumulated depreciation	(2,008,927)	(1,670,245)
Net property and equipment	1,106,036	1,187,378
Investment in SAVSU	1,070,120	2,075,000
Long-term deposits	36,166	36,166
Total assets	12,143,203	7,926,614
Current liabilities
Accounts payable	690,702	710,719
Accrued expenses and other current liabilities	200,548	116,399
Accrued compensation	491,432	175,829
Deferred rent, current portion	130,216	130,216
Total current liabilities	1,512,898	1,133,163
Promissory note payable to related party, net of discount of $155,996 at December 31, 2016	0	2,844,004
Accrued interest, related party	0	97,857
Deferred rent, long-term	492,207	685,450
Other long-term liabilities	45,512	0
Total liabilities	2,050,617	4,760,474
Commitments and Contingencies (Note 9)
Shareholders’ equity
Preferred stock, $0.001 par value; 1,000,000 shares authorized, Series A, 4,250 shares designated, and 4,250 and 0 shares issued and outstanding at December 31, 2017 and 2016, respectively	4	0
Common stock, $0.001 par value; 150,000,000 shares authorized, 14,021,422 and 12,863,824 shares issued and outstanding at December 31, 2017 and 2016, respectively	14,021	12,864
Additional paid-in capital	84,036,444	74,355,645
Accumulated deficit	(73,957,883)	(71,202,369)
Total BioLife Solutions, Inc. shareholders’ equity	10,092,586	3,166,140
Total liabilities and shareholders’ equity	$ 12,143,203	$ 7,926,614